Goldman Sachs’s Biote Corp BTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding BTMD
3C
BP
RHJA
Goldman Sachs's BTMD Position: Q2 2026 in Review
Goldman Sachs increased its Biote Corp (BTMD) stake by 114% in Q2 2026, buying an estimated $236K and bringing the position to 215,384 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #5828.
Goldman Sachs first reported a position in BTMD in Q2 2021 and has held it in 18 quarters since. The position peaked at $6.17M in Q1 2022. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.
- Goldman Sachs held 215,384 shares of Biote Corp worth $407K as of Q2 2026.
- Goldman Sachs bought 114,775 Biote Corp shares in Q2 2026, an estimated $236K.
- Biote Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5828 holding.
- Goldman Sachs first reported a position in Biote Corp in Q2 2021 and has held it in 18 quarters since.
- Goldman Sachs's Biote Corp position peaked at $6.17M in Q1 2022.
- 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.